Successful treatment with enfortumab–vedotin of metastatic signet ring cell cancer expressing nectin‐4 and originating from the bladder

Introduction As an aggressive adenocarcinoma phenotype, primary signet ring cell carcinoma of the urinary bladder is an extremely rare variant. The prognosis of metastatic signet ring cell carcinoma of the urinary bladder is extremely poor and the clinical course for its specific pathogenesis remain...

Full description

Bibliographic Details

Published in:	IJU Case Reports
Main Authors:	Maria Aoki, Taku Naiki, Aya Naiki‐Ito, Toshiharu Morikawa, Nayuka Matsuyama, Koei Torii, Taiki Kato, Tetsuji Maruyama, Shingo Inaguma, Takahiro Yasui
Format:	Article
Language:	English
Published:	Wiley 2024-03-01
Subjects:	enfortumab–vedotin image‐guided biopsy lymphatic metastasis nectins signet ring cell carcinoma of the urinary bladder
Online Access:	https://doi.org/10.1002/iju5.12678